FONAR Reports 33% Drop in Q3 Operating Income, EPS Plunges 35%
Summary
FONAR announced its third-quarter fiscal 2026 financial results, reporting a significant 33% decrease in income from operations to $2.4 million and a 35% decline in diluted net income per common share to $0.24 compared to the prior year. Net income for the quarter also fell 25% to $2.3 million, while total revenues-net decreased 3% to $26.5 million. For the nine-month period, operating income was down 19% and EPS declined 21%, with net cash provided by operating activities also significantly lower. These results confirm and quantify the operational decline hinted at in the recent DEF 14A filing, which noted a "significant decline in operati" and a "material weakness in IT internal controls." The substantial deterioration in profitability metrics is a material concern for investors, especially as the stock is trading near its 52-week high, and could trigger a negative market reaction. Traders will be watching for further commentary on the impact of these results on the company's outlook and the ongoing merger-related lawsuit mentioned in the last 10-Q.
At the time of this announcement, FONR was trading at $18.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $118.3M. The 52-week trading range was $12.24 to $18.95. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: TMX Newsfile.